TELA Bio (TELA) Cash from Operations (2018 - 2026)

TELA Bio's Cash from Operations history runs 9 years deep, the most recent figure standing at 11170000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 14.86% year-over-year to 11170000.0; the TTM figure through Mar 2026 stood at 29664000.0 (up 19.69% YoY), while the FY2025 annual figure was 28219000.0, up 32.16% from the prior year.
• Cash from Operations was 11170000.0 for Q1 2026 at TELA Bio, down from 4870000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 4870000.0 in Q4 2025 to a low of 14384000.0 in Q1 2024.
• Historically, Cash from Operations has averaged 9564058.82 across 5 years, with a median of 10430000.0 in 2022.
• The sharpest annual moves came in 2022 and 2025: Cash from Operations sank 107.6% in 2022, then surged 36.34% in 2025.
• A 5-year view of Cash from Operations shows it stood at 10983000.0 in 2022, then decreased by 0.62% to 11051000.0 in 2023, then jumped by 31.85% to 7531000.0 in 2024, then surged by 35.33% to 4870000.0 in 2025, then tumbled by 129.36% to 11170000.0 in 2026.
• The last three Cash from Operations figures came in at 11170000.0 (Q1 2026), 4870000.0 (Q4 2025), and 5719000.0 (Q3 2025), per Business Quant data.